ReviewSeminars in oncology2014
GD2-targeted immunotherapy and radioimmunotherapy.
Konstantin Dobrenkov et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
47 papers cite it
this papertrialcites it
ReviewSeminars in oncology2014
Konstantin Dobrenkov et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.